Key Findings

⌚ Wearable Data from ~90,000 People Links Body Clock Alignment to Disease Risk

• Analyzing week-long wrist sensor data from ~90,000 UK Biobank participants (median age 63), researchers measured how well each person's physical activity and wrist temperature rhythms stayed in sync over 24 hours
• Stronger coupling between activity and temperature rhythms was associated with lower risk of type 2 diabetes, cardiovascular disease, depression, sleep apnea, and all-cause mortality over 7–11 years of follow-up
• Greater phase deviation (when the two rhythms drift out of their expected relationship) was linked to higher cardiometabolic risk
• Results were replicated in a separate cohort (SHARE), supporting the consistency of the approach across different devices

🧠 Reinforcing the Body Clock After Stroke Improved Recovery in Mice

• In mouse models of stroke, four different interventions — a clock-modulating molecule (KL001), high-dose melatonin, timed light pulses, and time-restricted feeding during the active phase — each enhanced glymphatic function (the brain's waste-clearance system)
• When KL001 or active-phase time-restricted feeding was started 3 days after stroke, mice showed improved motor outcomes, smaller lesion volumes, increased glymphatic flow, and lower brain cytokine levels (markers of inflammation)
• The interventions worked even when started days after the stroke — not immediately — which is relevant to real-world treatment windows
• These findings are in mice, and translation to humans requires further study

🩸 Night Shift Work Linked to Higher Blood Pressure — Mitochondria May Be the Bridge

• In mice, simulated night shift work elevated blood pressure and disrupted circadian clock genes (PER1, BMAL1), alongside signs of mitochondrial dysfunction and oxidative stress — measured at 4 and 10 weeks
• In human night shift workers, longer exposure duration was quantitatively associated with higher systolic and diastolic blood pressure, with concurrent dysregulation of both circadian and mitochondrial markers
• Expression levels of these markers correlated with both shift work exposure duration and blood pressure readings
• This was an observational study in humans, so causation cannot be confirmed

🌙 Light Pollution Exposure Grew from 4.3B to 6.3B People Between 2000–2020

• Merging two satellite datasets, researchers tracked global population exposure to outdoor artificial light at night (ALAN) from 2000 to 2020 — a 47% increase in the number of people exposed
• 88% of that growth occurred in medium-to-high light emission areas, mostly suburban and urban regions
• 73% of the increase in high-emission exposure (urban areas) is attributed to population growth and migration; in suburban areas, rising light intensity itself accounts for 63% of the increase
• By 2050, projections suggest nearly 70% of further growth will occur in medium-to-high light emission zones

🦷 Disrupted Body Clock in Pregnant Mice Linked to Weaker Tooth Enamel in Offspring

• Maternal circadian disruption in mice led to impaired enamel mineralization in offspring — characterized by reduced thickness and density, a higher carbonate-to-phosphate ratio (a marker of weaker mineral quality), and disorganized surface structure
• Melatonin given to pregnant mice under circadian disruption partially rescued these enamel defects
• Knocking down BMAL1 (a core clock gene) in enamel-forming cells disrupted mitochondrial function and reduced mineralization; melatonin restored mitochondrial activity and suppressed overactivation of JNK3 (a stress-signaling protein)
• These are mouse and cell-culture findings — human relevance is not yet established

💊 22mg Cumulative Melatonin Dose Linked to Lowest Delirium Risk in ICU Patients

• A meta-analysis of 24 randomized controlled trials (3,680 ICU patients total) found melatonin or ramelteon (a melatonin receptor agonist) reduced delirium incidence vs. placebo: RR 0.77 (95% CI: 0.62–0.94)
• A nonlinear dose-response analysis suggested an optimal cumulative melatonin dose of ~22mg, with an associated RR of 0.73 (95% CI: 0.60–0.90) for delirium
• Effects were stronger in surgical ICUs (RR 0.64, 95% CI: 0.48–0.87) and with interventions lasting ≥7 days (RR 0.73, 95% CI: 0.60–0.90)
• No significant effect on ICU mortality or adverse events was observed; evidence certainty was rated low-to-moderate with moderate heterogeneity across studies